Contract development and manufacturing organisation (CDMO), Recipharm, has been recognised in the CMO Leadership Awards for 2018, organised by Life Science Leader.
Award-stars
The awards acknowledge service excellence across pharmaceutical contract manufacturers and each company looked at by the organisers are assessed over six areas: quality, reliability, capabilities, expertise, compatibility and service.
Award winners are identified through an Industry Standard Research (ISR) survey, which obtains third-party feedback from sponsor companies. This year, more than 80 CMOs were measured against 26 performance indicators and ranked accordingly. Recipharm was selected as a winner in all six categories.
“We’re delighted to have again been rewarded for our efforts as part of the CMO Leaderships Awards. These awards in particular allow us to gain an uncensored insight into how our customers feel we’re performing so it’s great to be recognised year on year,” stated Thomas Eldered, CEO at Recipharm. “At Recipharm, we’re dedicated to offering not only quality development and manufacturing services, but also ensuring our customers benefit from our expertise and wide-ranging capabilities, so to be recognised in all six categories this year is a fantastic achievement for us.”